Financials

News Ideas Technicals

SVA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Sinovac Biotech, Ltd.

Total assets of SVA for H2 23 is 13.66 B USD, 0.49% less than the previous H1 23. And total liabilities increased by 10.00% in H2 23 to 1.63 B USD.

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—